Literature DB >> 20680640

Is there a correlation between 18F-FDG-PET standardized uptake value, T-classification, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck?

Stephan K Haerle1, G F Huber, T F Hany, N Ahmad, D T Schmid.   

Abstract

UNLABELLED: (18)F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET)/CT imaging of squamous cell carcinoma of the head and neck (HNSCC) renders the possibility to study metabolic tumor activity by measuring FDG-uptake expressed as maximum standardized uptake value (SUV(max)). A correlation between SUV(max) and several factors including T-classification, histological tumor differentiation or different anatomic subsites is of potential interest in HNSCC. The aim of this study was to evaluate how metabolic tumor activity derived from FDG-PET correlates with prognostic clinical and pathological parameters including these factors. 262 patients with HNSCC undergoing PET/CT for initial staging were assessed separately for a potential correlation between SUV(max) and T-classification, histological grading, and anatomical subsites of the primary tumor. Nonparametric testing showed a significant correlation between SUV(max) and T-classification (P < 0.001). On the contrary, no statistically significant correlation was found between SUV(max) and histological tumor grading. Furthermore, no statistical significant correlation between the different anatomical subsites and SUV(max) were found. There was no significant correlation of SUV(max) and tumor grading after adjustment for T-stage and anatomical localization of the tumor, neither.
CONCLUSION: Metabolic tumor activity correlates with T-stage of HNSCC. However, histological tumor grading does not correlate with SUV(max). The role of primary tumor SUV(max) as a predictor of outcome or survival remains unclear. Clinicians should therefore exercise caution in attributing any clinical importance to SUV(max) obtained from a single PET/CT exam.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20680640     DOI: 10.1007/s00405-010-1348-2

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  21 in total

1.  FDG-PET prediction of head and neck squamous cell cancer outcomes.

Authors:  David L Schwartz; Joseph Rajendran; Bevan Yueh; Marc D Coltrera; Michael Leblanc; Janet Eary; Kenneth Krohn
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-12

2.  Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer.

Authors:  Mitchell Machtay; Mona Natwa; Jocelyn Andrel; Terry Hyslop; P Rani Anne; Jororsali Lavarino; Charles M Intenzo; William Keane
Journal:  Head Neck       Date:  2009-02       Impact factor: 3.147

3.  FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.

Authors:  Yoshimasa Kitagawa; Kazuo Sano; Sadahiko Nishizawa; Mikiko Nakamura; Toshiyuki Ogasawara; Norihiro Sadato; Yoshiharu Yonekura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-10-26       Impact factor: 9.236

4.  FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma.

Authors:  Eva Brun; Elisabeth Kjellén; Jan Tennvall; Tomas Ohlsson; Anders Sandell; Roland Perfekt; Roland Perfekt; Johan Wennerberg; Sven Erik Strand
Journal:  Head Neck       Date:  2002-02       Impact factor: 3.147

5.  Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients.

Authors:  Carin A Uyl-de Groot; Asaf Senft; Remco de Bree; C René Leemans; Otto S Hoekstra
Journal:  J Nucl Med       Date:  2010-02       Impact factor: 10.057

6.  Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study.

Authors:  Max Lonneux; Marc Hamoir; Hervé Reychler; Philippe Maingon; Christian Duvillard; Gilles Calais; Boumédiène Bridji; Laurence Digue; Michel Toubeau; Vincent Grégoire
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

7.  (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma.

Authors:  Stephan K Haerle; Klaus Strobel; Thomas F Hany; Daniel Sidler; Sandro J Stoeckli
Journal:  Head Neck       Date:  2010-03       Impact factor: 3.147

8.  Flow cytometric analysis of squamous cell carcinomas of the oral cavity in relation to lymph node metastasis.

Authors:  R B Chen; K Suzuki; T Nomura; T Nakajima
Journal:  J Oral Maxillofac Surg       Date:  1993-04       Impact factor: 1.895

Review 9.  Clinical applications of PET in oncology.

Authors:  Eric M Rohren; Timothy G Turkington; R Edward Coleman
Journal:  Radiology       Date:  2004-03-24       Impact factor: 11.105

10.  FDG-PET. A possible prognostic factor in head and neck cancer.

Authors:  W Halfpenny; S F Hain; L Biassoni; M N Maisey; J A Sherman; M McGurk
Journal:  Br J Cancer       Date:  2002-02-12       Impact factor: 7.640

View more
  10 in total

1.  Predictive value of fluorodeoxyglucose uptake in head and neck cancer: importance of standardization: editorial on EAORL-D-10-00277.

Authors:  Remco de Bree; Otto S Hoekstra
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-08-04       Impact factor: 2.503

2.  Arterial spin labeling perfusion-weighted MR imaging: correlation of tumor blood flow with pathological degree of tumor differentiation, clinical stage and nodal metastasis of head and neck squamous cell carcinoma.

Authors:  Ahmed Abdel Khalek Abdel Razek; Nadia Nada
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-27       Impact factor: 2.503

3.  Asphericity of pretherapeutic tumour FDG uptake provides independent prognostic value in head-and-neck cancer.

Authors:  Ivayla Apostolova; Ingo G Steffen; Florian Wedel; Alexandr Lougovski; Simone Marnitz; Thorsten Derlin; Holger Amthauer; Ralph Buchert; Frank Hofheinz; Winfried Brenner
Journal:  Eur Radiol       Date:  2014-06-26       Impact factor: 5.315

4.  Prognostic value of tumour blood flow, [¹⁸F]EF5 and [¹⁸F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy.

Authors:  Gaber Komar; Kaisa Lehtiö; Marko Seppänen; Olli Eskola; Helena Levola; Paula Lindholm; Hannu Sipilä; Jan Seppälä; Reidar Grénman; Olof Solin; Heikki Minn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-06-05       Impact factor: 9.236

5.  Associations Between [18F]FDG-PET and Complex Histopathological Parameters Including Tumor Cell Count and Expression of KI 67, EGFR, VEGF, HIF-1α, and p53 in Head and Neck Squamous Cell Carcinoma.

Authors:  Alexey Surov; Hans Jonas Meyer; Anne-Kathrin Höhn; Karsten Winter; Osama Sabri; Sandra Purz
Journal:  Mol Imaging Biol       Date:  2019-04       Impact factor: 3.488

6.  Application of integrated positron emission tomography/magnetic resonance imaging in evaluating the prognostic factors of head and neck squamous cell carcinoma with positron emission tomography, diffusion-weighted imaging, dynamic contrast enhancement and combined model.

Authors:  Haodan Dang; Yu Chen; Zhuhua Zhang; Xiaohua Shi; Xingming Chen; Xiaoli Zhu; Bo Hou; Haiqun Xing; Huadan Xue; Zhengyu Jin
Journal:  Dentomaxillofac Radiol       Date:  2020-04-03       Impact factor: 2.419

7.  Functional imaging of head and neck squamous cell carcinoma with diffusion-weighted MRI and FDG PET/CT: quantitative analysis of ADC and SUV.

Authors:  Arthur Varoquaux; Olivier Rager; Karl-Olof Lovblad; Karen Masterson; Pavel Dulguerov; Osman Ratib; Christoph D Becker; Minerva Becker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-02-22       Impact factor: 9.236

8.  [18F]Fluorodeoxyglucose uptake by positron emission tomography predicts outcomes for oropharyngeal and hypopharyngeal cancer treated with definitive radiotherapy.

Authors:  Takeaki Ishihara; Kazuhiro Kitajima; Yuko Suenaga; Yasuo Ejima; Hirokazu Komatsu; Naoki Otsuki; Ken-Ichi Nibu; Naomi Kiyota; Satoru Takahashi; Ryohei Sasaki
Journal:  Nagoya J Med Sci       Date:  2017-02       Impact factor: 1.131

9.  Correlation of Positron Emission Tomography/Computed Tomography Scan with Smoking, Tumor Size, Stage and Differentiation in Head and Neck Cancer Patients.

Authors:  Jordan L Pleitz; Partha Sinha; Emily V Dressler; Rony K Aouad
Journal:  World J Nucl Med       Date:  2017 Jan-Mar

10.  Combined Metabolo-Volumetric Parameters of 18F-FDG-PET and MRI Can Predict Tumor Cellularity, Ki67 Level and Expression of HIF 1alpha in Head and Neck Squamous Cell Carcinoma: A Pilot Study.

Authors:  Alexey Surov; Hans Jonas Meyer; Anne Kathrin Höhn; Osama Sabri; Sandra Purz
Journal:  Transl Oncol       Date:  2018-09-18       Impact factor: 4.243

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.